Calprest NG— 510(k) K160447

Substantially Equivalent

Eurospital S.P.A.

FDA 510(k) clearance K160447 for Calprest NG, Substantially Equivalent on 2016-11-10. Applicant: Eurospital S.P.A..

Clearance details

Applicant: Eurospital S.P.A.
Product code: Code NXO
Advisory panel: Immunology
Date received: 2016-02-17
Decision date: 2016-11-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Trieste, IT

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.